Complete Filing Data
Biofrontera Inc. reported Stockholders Equity of $10.48 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Biofrontera Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $41.7M | $37.3M | $34.1M | $28.7M | $24.1M | $18.8M |
| Operating Income Loss | -$11.3M | -$17.2M | -$22.7M | -$18.6M | -$25.2M | -$9.6M |
| Nonoperating Income Expense | $837.0K | -$527.0K | $2.6M | $18.0M | -$12.5M | -$1.3M |
| Net Income Loss | -$10.5M | -$17.8M | -$20.1M | -$640.0K | -$37.7M | -$11.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$10.5M | -$17.7M | -$20.1M | -$608.0K | -$37.7M | -$10.9M |
| Income Tax Expense Benefit | $25.0K | $22.0K | $14.0K | $32.0K | $56.0K | $64.0K |
| Operating Expenses | $56.7M | $47.3M | $49.3M | $28.5M | ||
| Amortization Of Intangible Assets | $329.0K | $418.0K | $418.0K | $418.0K | $418.0K | |
| Interest Income Expense Net | -$468.0K | -$195.0K | -$344.0K | -$2.9M | ||
| Other Nonoperating Income Expense | $388.0K | $158.0K | -$75.0K | $33.0K | $689.0K | $1.6M |
| Noncash Interest Expense | $491.0K | $297.0K | $402.0K | $358.0K | $358.0K | $358.0K |
| Selling General And Administrative Expense | $37.8M | $33.8M | $39.0M | $35.1M | $36.5M | $17.7M |
| Income Taxes Paid Net | $25.0K | $24.0K | $15.0K | $32.0K | $56.0K | $64.0K |
| Products Revenues Net | $41.7M | $37.3M | $34.0M | $28.5M | $24.0M | |
| Research And Development Expense | $3.7M | $2.1M | $77.0K | |||
| Related Parties Amount In Cost Of Sales | $16.8M | $14.6M | $12.2M | $8.3M | ||
| Revenues Related Party | $18.0K | $66.0K | $133.0K | |||
| Income Loss From Equity Method Investments | $2.0K | -$14.0K | -$7.4M | $1.7M | ||
| Cost Of Revenues | $567.0K | $520.0K | ||||
| Cost Of Goods And Services Sold |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $7.0M | $9.0M | $8.6M | $9.0M | $7.8M | $7.9M | $8.9M | $5.8M | $8.7M | $4.3M | $4.5M | $9.8M | $4.3M | $5.9M | $4.7M | $3.3M |
| Operating Income Loss | -$6.3M | -$5.1M | -$4.5M | -$5.0M | -$5.1M | -$5.5M | -$4.6M | -$8.7M | -$5.5M | -$3.6M | -$6.2M | -$3.1M | -$16.1M | -$3.7M | -$3.5M | -$2.3M |
| Nonoperating Income Expense | -$365.0K | -$224.0K | $343.0K | -$706.0K | $4.8M | -$5.0M | -$1.7M | -$1.1M | -$2.0M | $1.1M | $5.4M | $8.7M | $99.0K | $70.0K | -$5.0K | -$580.0K |
| Net Income Loss | -$6.6M | -$5.3M | -$4.2M | -$5.7M | -$257.0K | -$10.4M | -$6.3M | -$9.8M | -$7.5M | -$2.6M | -$850.0K | $5.6M | -$16.0M | -$3.7M | -$3.5M | -$3.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.6M | -$5.3M | -$4.2M | -$5.7M | -$237.0K | -$10.4M | -$6.3M | -$9.8M | -$7.5M | -$2.6M | -$850.0K | $5.6M | -$16.0M | -$3.6M | -$3.5M | -$2.9M |
| Income Tax Expense Benefit | $6.0K | $21.0K | -$1.0K | $3.0K | $20.0K | $1.0K | $1.0K | $14.0K | $5.0K | $1.0K | $30.0K | $6.0K | $44.0K | $1.0K | $61.0K | |
| Operating Expenses | $14.0M | $12.9M | $13.4M | $13.5M | $14.5M | $14.2M | $8.0M | $10.7M | $12.9M | $20.4M | $9.5M | $8.3M | ||||
| Amortization Of Intangible Assets | $4.0K | $100.0K | $107.0K | $100.0K | $100.0K | $105.0K | $100.0K | $100.0K | $105.0K | $100.0K | $105.0K | |||||
| Interest Income Expense Net | -$596.0K | -$1.4M | -$142.0K | -$79.0K | -$35.0K | -$89.0K | -$38.0K | -$33.0K | -$86.0K | -$85.0K | -$84.0K | -$744.0K | ||||
| Other Nonoperating Income Expense | $30.0K | -$264.0K | -$99.0K | -$32.0K | $6.0K | $180.0K | $35.0K | $62.0K | -$33.0K | -$22.0K | $29.0K | $23.0K | $185.0K | $79.0K | $164.0K | |
| Noncash Interest Expense | $119.0K | $151.0K | $89.0K | $89.0K | $89.0K | |||||||||||
| Selling General And Administrative Expense | $10.0M | $10.5M | $8.7M | $8.4M | $7.9M | $9.3M | $8.6M | $11.5M | $9.8M | $7.8M | $9.7M | $7.6M | $17.1M | $5.6M | $4.8M | $4.2M |
| Income Taxes Paid Net | $22.0K | $30.0K | $1.0K | |||||||||||||
| Products Revenues Net | $7.0M | $9.0M | $8.6M | $9.0M | $7.8M | $7.9M | $8.9M | $5.8M | $8.7M | $4.3M | $4.4M | $9.7M | ||||
| Research And Development Expense | $854.0K | $870.0K | $1.2M | $669.0K | $621.0K | $17.0K | $33.0K | $11.0K | ||||||||
| Related Parties Amount In Cost Of Sales | $4.5M | $2.8M | $4.5M | $2.1M | $2.4M | $5.0M | $2.2M | $3.0M | $2.4M | $567.0K | ||||||
| Revenues Related Party | $8.0K | $11.0K | $17.0K | $18.0K | $18.0K | $32.0K | $16.0K | $15.0K | ||||||||
| Income Loss From Equity Method Investments | -$14.0K | $3.0K | -$2.2M | -$1.5M | -$2.9M | |||||||||||
| Cost Of Revenues | $95.0K | $116.0K | $51.0K | $98.0K | $152.0K | $175.0K | $41.0K | $135.0K | $163.0K | |||||||
| Cost Of Goods And Services Sold | $41.0K | $446.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $10.5M | $4.4M | $4.8M | $23.9M | $11.3M | $5.8M | -$30.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $6.6M | $6.1M | $1.5M | $17.4M | $24.7M | $8.3M | $7.5M |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $100.0K | -$3.8M | -$1.4M | $140.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $487.0K | $4.6M | -$15.9M | -$7.3M | $16.5M | $825.0K | |
| Cash And Cash Equivalents At Carrying Value | $6.4M | $5.9M | $1.3M | $17.2M | $24.5M | $8.1M | |
| Retained Earnings Accumulated Deficit | -$127.9M | -$117.4M | -$99.7M | -$79.5M | -$78.9M | -$41.2M | |
| Property Plant And Equipment Net | $2.2M | $80.0K | $134.0K | $204.0K | $267.0K | $370.0K | |
| Prepaid Expense And Other Assets Current | $2.3M | $527.0K | $425.0K | $810.0K | $5.0M | $1.1M | |
| Other Liabilities Noncurrent | $9.0K | $23.0K | $37.0K | $21.0K | $5.6M | $62.0K | |
| Other Assets | $360.0K | $383.0K | $482.0K | $320.0K | $268.0K | $323.0K | |
| Liabilities Current | $11.9M | $12.0M | $18.1M | $20.9M | $13.8M | $4.4M | |
| Liabilities And Stockholders Equity | $28.6M | $22.1M | $27.9M | $50.9M | $53.2M | $24.1M | |
| Liabilities | $18.1M | $17.7M | $23.1M | $27.0M | $41.9M | $18.3M | |
| Inventory Net | $1.4M | $6.6M | $10.9M | $7.2M | $4.5M | $7.1M | |
| Intangible Assets Net Excluding Goodwill | $2.7M | $35.0K | $2.6M | $3.0M | $3.5M | $3.9M | |
| Assets Current | $18.1M | $20.7M | $23.1M | $43.1M | $46.4M | $19.6M | |
| Assets | $28.6M | $22.1M | $27.9M | $50.9M | $53.2M | $24.1M | |
| Accounts Payable And Other Accrued Liabilities Current | $4.9M | $4.3M | $4.5M | $10.9M | $9.7M | $2.7M | |
| Common Stock Value | $12.0K | $9.0K | $2.0K | $1.0K | $17.0K | $8.0K | |
| Warrant Liabilities Non Current | $351.0K | $1.3M | $4.2M | $2.8M | $12.9M | ||
| Gain Loss On Investments | $2.0K | -$14.0K | -$7.4M | $1.7M | |||
| Accounts Receivable Net | $7.3M | $5.3M | $5.2M | $3.7M | $3.8M | $3.2M | |
| Operating Lease Right Of Use Asset | $1.6M | $903.0K | $1.6M | $1.8M | $1.8M | ||
| Operating Lease Liability Noncurrent | $1.2M | $276.0K | $804.0K | $848.0K | |||
| Operating Lease Liability Current | $332.0K | $548.0K | $691.0K | $498.0K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $730.0K | $728.0K | $560.0K | $653.0K | |||
| Inventory Write Down | $100.0K | $33.0K | $401.0K | ||||
| Business Combination Contingent Consideration Liability Noncurrent | $2.4M | $9.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$2.6M | -$4.7M | $500.0K | $5.5M | $10.9M | -$5.4M | $1.0M | $7.2M | $16.8M | $22.6M | $17.2M | $17.4M | -$17.4M | -$1.4M | $2.3M | -$41.0M | -$38.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.6M | $7.4M | $2.0M | $3.1M | $4.6M | $4.0M | $3.6M | $4.7M | $13.7M | $27.8M | $32.1M | $22.6M | $1.9M | $3.2M | $4.8M | $4.6M | |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $200.0K | $100.0K | -$200.0K | -$2.2M | -$1.9M | $700.0K | $500.0K | $498.0K | $100.0K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.1M | $2.5M | -$3.7M | -$2.1M | -$3.4M | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $3.4M | $7.2M | $1.8M | $2.9M | $4.4M | $3.8M | $3.4M | $4.5M | $1.3M | $27.5M | $31.9M | $22.4M | $1.7M | ||||
| Retained Earnings Accumulated Deficit | -$133.6M | -$126.9M | -$121.6M | -$116.0M | -$110.3M | -$110.1M | -$103.2M | -$96.8M | -$87.0M | -$76.7M | -$74.2M | -$73.3M | -$64.4M | ||||
| Property Plant And Equipment Net | $20.0K | $37.0K | $59.0K | $82.0K | $101.0K | $120.0K | $154.0K | $175.0K | $197.0K | $224.0K | $248.0K | $245.0K | $289.0K | ||||
| Prepaid Expense And Other Assets Current | $629.0K | $331.0K | $682.0K | $350.0K | $473.0K | $560.0K | $274.0K | $929.0K | $1.6M | $3.8M | $1.2M | $1.4M | $936.0K | ||||
| Other Liabilities Noncurrent | $12.0K | $14.0K | $21.0K | $29.0K | $31.0K | $33.0K | $38.0K | $40.0K | $24.0K | $5.6M | $5.7M | $5.7M | $5.6M | ||||
| Other Assets | $472.0K | $535.0K | $453.0K | $383.0K | $324.0K | $328.0K | $492.0K | $504.0K | $384.0K | $393.0K | $343.0K | $268.0K | $1.4M | ||||
| Liabilities Current | $12.6M | $19.7M | $11.0M | $11.0M | $9.3M | $14.0M | $29.1M | $25.4M | $20.5M | $17.1M | $14.9M | $12.4M | $11.3M | ||||
| Liabilities And Stockholders Equity | $15.4M | $20.1M | $16.6M | $18.5M | $21.6M | $24.6M | $34.1M | $36.9M | $42.0M | $55.1M | $53.6M | $49.2M | $15.4M | ||||
| Liabilities | $18.0M | $24.8M | $16.1M | $13.0M | $10.7M | $26.4M | $33.1M | $29.7M | $25.2M | $32.5M | $36.4M | $31.8M | $32.7M | ||||
| Inventory Net | $4.3M | $4.0M | $6.5M | $6.5M | $3.9M | $6.9M | $16.1M | $14.8M | $6.7M | $12.1M | $8.8M | $4.9M | $5.4M | ||||
| Intangible Assets Net Excluding Goodwill | $22.0K | $26.0K | $31.0K | $39.0K | $2.4M | $2.6M | $2.7M | $2.8M | $2.9M | $3.1M | $3.2M | $3.3M | $3.6M | ||||
| Assets Current | $14.4M | $18.8M | $15.3M | $16.9M | $17.5M | $20.2M | $29.6M | $32.3M | $37.2M | $48.5M | $47.0M | $42.5M | $10.1M | ||||
| Assets | $15.4M | $20.1M | $16.6M | $18.5M | $21.6M | $24.6M | $34.1M | $36.9M | $42.0M | $55.1M | $53.6M | $49.2M | $15.4M | ||||
| Accounts Payable And Other Accrued Liabilities Current | $6.6M | $5.8M | $4.6M | $4.7M | $3.6M | $4.2M | $11.0M | $10.7M | $11.1M | $9.4M | $9.4M | $8.5M | $9.3M | ||||
| Common Stock Value | $12.0K | $9.0K | $9.0K | $7.0K | $5.0K | $5.0K | $1.0K | $27.0K | $27.0K | $23.0K | $19.0K | $17.0K | $8.0K | ||||
| Warrant Liabilities Non Current | $833.0K | $548.0K | $702.0K | $1.6M | $921.0K | $11.7M | $842.0K | $1.4M | $1.8M | $4.0M | $8.0M | $4.1M | |||||
| Gain Loss On Investments | $1.0K | $2.0K | -$2.0K | -$14.0K | $3.0K | -$2.2M | -$1.5M | -$2.9M | |||||||||
| Accounts Receivable Net | $3.0M | $4.0M | $4.0M | $4.9M | $3.5M | $3.5M | $3.8M | $2.2M | $4.1M | $1.6M | $2.0M | $5.2M | $2.0M | ||||
| Operating Lease Right Of Use Asset | $488.0K | $729.0K | $713.0K | $1.1M | $1.2M | $1.4M | $1.1M | $1.1M | $1.2M | ||||||||
| Operating Lease Liability Noncurrent | $136.0K | $223.0K | $220.0K | $324.0K | $443.0K | $621.0K | $562.0K | $600.0K | $725.0K | ||||||||
| Operating Lease Liability Current | $307.0K | $443.0K | $426.0K | $670.0K | $701.0K | $690.0K | $555.0K | $489.0K | $484.0K | ||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $190.0K | $179.0K | $139.0K | ||||||||||||||
| Inventory Write Down | $35.0K | ||||||||||||||||
| Business Combination Contingent Consideration Liability Noncurrent | $2.5M | $2.3M | $2.2M | $5.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$13.4M | -$10.3M | -$24.9M | -$16.2M | -$26.7M | -$12.4M |
| Increase Decrease In Inventories | -$1.4M | -$4.2M | $3.8M | $2.8M | -$2.6M | $273.0K |
| Increase Decrease In Accounts Receivable | $1.9M | $315.0K | $1.5M | $70.0K | $612.0K | -$1.2M |
| Net Cash Provided By Used In Financing Activities | $10.9M | $14.8M | $8.4M | $14.0M | $43.2M | $13.2M |
| Net Cash Provided By Used In Investing Activities | $3.0M | -$3.0K | $619.0K | -$5.2M | -$11.0K | |
| Share Based Compensation | $951.0K | $1.0M | $1.0M | $1.9M | $129.0K | |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | $6.4M | $912.0K | -$773.0K | -$3.4M | ||
| Increase Decrease In Due From Other Related Parties Current | -$2.0K | -$6.5M | -$5.0M | $11.4M | ||
| Payments To Acquire Property Plant And Equipment | $2.0K | $10.0K | $5.0K | $38.0K | ||
| Increase Decrease In Operating Lease Liability | -$683.0K | -$689.0K | -$657.0K | -$781.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.7M | $141.0K | -$174.0K | -$4.2M | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $610.0K | -$230.0K | -$6.4M | -$3.6M | ||
| Increase Decrease In Prepaid Expenses Other | -$4.2M | $3.8M | -$364.0K | |||
| Increase Decrease In Other Accrued Liabilities | -$3.6M | $12.5M | -$685.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$4.1M | -$3.3M | -$3.7M | -$2.1M | -$3.4M |
| Increase Decrease In Inventories | -$119.0K | -$4.0M | -$499.0K | $414.0K | $1.4M |
| Increase Decrease In Accounts Receivable | -$1.3M | -$1.6M | $381.0K | $1.4M | -$1.5M |
| Net Cash Provided By Used In Financing Activities | $5.8M | ||||
| Net Cash Provided By Used In Investing Activities | -$3.0K | -$14.0K | -$5.0K | ||
| Share Based Compensation | $239.0K | $228.0K | $351.0K | $517.0K | |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | -$2.3M | -$792.0K | -$366.0K | -$922.0K | |
| Increase Decrease In Due From Other Related Parties Current | $165.0K | -$2.7M | $38.0K | ||
| Payments To Acquire Property Plant And Equipment | $3.0K | $57.0K | $14.0K | ||
| Increase Decrease In Operating Lease Liability | -$179.0K | -$166.0K | -$134.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $224.0K | $119.0K | $830.0K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $307.0K | -$261.0K | $274.0K | ||
| Increase Decrease In Prepaid Expenses Other | $830.0K | -$3.6M | $83.0K | ||
| Increase Decrease In Other Accrued Liabilities | $274.0K | -$1.1M | $193.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.04 | -$3.22 | -$13.02 | -$0.61 | -$4.28 | -$479.48 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 10.2M | 5.5M | 1.5M | 1.1M | 8.8M | |
| Earnings Per Share Basic | $-1.04 | $-3.22 | $-13.02 | $-0.61 | $-4.28 | |
| Common Stock Shares Authorized | 70.0M | 70.0M | 35.0M | 15.0M | 300.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 10.2M | 5.5M | 1.5M | 1.1M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | ||
| Common Stock Shares Outstanding | 11.6M | 8.9M | 1.5M | 1.3M | 17.1M | 8.0M |
| Common Stock Shares Issued | 11.6M | 8.9M | 1.5M | 1.3M | 17.1M | 8.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.62 | -$0.57 | -$0.47 | -$0.98 | -$0.05 | -$2.88 | -$4.64 | -$7.23 | -$5.60 | -$2.26 | -$0.90 | $0.32 | -$2.00 | -$0.46 | -$0.44 | -$3.0K | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 10.8M | 9.4M | 8.9M | 5.8M | 5.1M | 3.6M | 1.4M | 1.4M | 1.3M | 1.1M | 941.2K | 17.1M | 8.0M | 8.0M | 8.0M | |||
| Earnings Per Share Basic | $-0.62 | $-0.57 | $-0.47 | $-0.98 | $-0.05 | $-2.88 | $-4.64 | $-7.23 | $-5.60 | $-2.26 | $-0.90 | $0.33 | $-2.00 | $-0.46 | $-0.44 | |||
| Common Stock Shares Authorized | 70.0M | 35.0M | 35.0M | 35.0M | 15.0M | 15.0M | 15.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 15.0M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 10.8M | 9.4M | 8.9M | 5.8M | 5.1M | 3.6M | 1.4M | 1.4M | 1.3M | 1.1M | 941.2K | 17.1M | 8.0M | 8.0M | 8.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||||||
| Common Stock Shares Outstanding | 11.6M | 10.1M | 8.9M | 6.5M | 5.1M | 5.1M | 1.4M | 1.4M | 26.7M | 23.6M | 19.0M | 17.1M | 8.0M | |||||
| Common Stock Shares Issued | 11.6M | 10.1M | 8.9M | 6.5M | 5.1M | 5.1M | 1.4M | 1.4M | 26.7M | 23.6M | 19.0M | 17.1M | 8.0M | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$899.0K | -$1.7M | -$6.5M | -$19.0M | $12.8M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $951.0K | $1.0M | $1.0M | $1.9M | $129.0K | |
| Depreciation | $92.0K | $86.0K | $101.0K | $122.0K | $144.0K | |
| Provision For Doubtful Accounts | -$69.0K | $162.0K | $122.0K | $106.0K | $44.0K | -$16.0K |
| Interest Paid Net | $6.0K | $1.7M | $125.0K | $1.0K | $2.0K | |
| Additional Paid In Capital | $138.4M | $121.8M | $104.4M | $103.4M | $90.2M | |
| Costs And Expenses Related Party | $152.0K | $733.0K | $697.0K | $411.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $285.0K | -$153.0K | -$548.0K | $680.0K | -$5.4M | $3.4M | -$598.0K | -$375.0K | -$1.0M | -$3.8M | -$5.4M | -$8.7M | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $236.0K | $187.0K | $239.0K | $288.0K | $204.0K | $228.0K | $207.0K | $259.0K | $351.0K | $401.0K | $551.0K | $517.0K | ||||
| Depreciation | $25.0K | $21.0K | $22.0K | $26.0K | $26.0K | $29.0K | $33.0K | $33.0K | $36.0K | |||||||
| Provision For Doubtful Accounts | -$46.0K | $66.0K | $14.0K | $42.0K | ||||||||||||
| Interest Paid Net | $1.2M | $4.0K | ||||||||||||||
| Additional Paid In Capital | $131.0M | $122.3M | $122.1M | $121.5M | $121.3M | $104.7M | $104.2M | $104.0M | $103.7M | $99.3M | $91.4M | $90.7M | ||||
| Costs And Expenses Related Party | $74.0K | $92.0K | $27.0K | $171.0K | $346.0K | $95.0K | $160.0K | $196.0K | $164.0K | $111.0K |
Most recent annual filing with the SEC: March 19, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.